Sign Up to like & get
recommendations!
1
Published in 2020 at "Bone Marrow Transplantation"
DOI: 10.1038/s41409-020-01136-2
Abstract: The goal of therapy in AL amyloidosis is to inhibit further production of the amyloidogenic light chains, thereby allowing organ recovery and improving survival. We aimed to assess the impact of depth of hematologic response…
read more here.
Keywords:
response;
depth response;
light;
amyloidosis ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2018 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2018.36.15_suppl.7514
Abstract: 7514Background: While it has been established that attainment of a complete response (CR) after chemoimmunotherapy improves progression free survival (PFS), this has not been proven with the BTK in...
read more here.
Keywords:
depth response;
free survival;
progression free;
response progression ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2019 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2019.37.15_suppl.8026
Abstract: 8026 Background: MRD assessment is a known surrogate marker for survival in multiple myeloma (MM). Most data come from patients enrolled in clinical trials. We present a single institution’s experience assessing MRD in patients receiving…
read more here.
Keywords:
response;
monitoring;
multiple myeloma;
disease ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2021 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2021.39.15_suppl.8049
Abstract: 8049 Background: The treatment paradigm of Waldenström macroglobulinemia (WM) continues to evolve as new therapies expand our options for this indolent and incurable disease. While more profound responses are generally associated with longer treatment-free intervals,…
read more here.
Keywords:
therapy;
response;
major response;
impact depth ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2021 at "Translational Cancer Research"
DOI: 10.21037/tcr-20-2547
Abstract: Response Evaluation Criteria in Solid Tumors (RECIST 1.1) is classical and popular for public. However, there are some problems recently. For example, partial response ranges from 30% to 99%, objective response is dichotomous, so there…
read more here.
Keywords:
cancer;
response;
predictor long;
solid tumors ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2019 at "Journal of Cancer"
DOI: 10.7150/jca.33450
Abstract: Background: Response Evaluation Criteria in Solid Tumors (RECIST) has been widely utilized to evaluate new therapeutic strategies in cancer. However, RECIST fails to assess the heterogeneity of response in highly active therapies. Depth of response…
read more here.
Keywords:
response;
depth response;
treated egfr;
cancer ... See more keywords